ARCHIVES

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

DCT Board Approves Drug Development Recompetition

November 30, 1990

In Brief: Weissman Heads DCBD Board; Extra Money For Grants Lifts Funding Level To 35%

October 14, 1977

MD Anderson Completes $500 Million Research Endowment

September 24, 2010

FDA Approves Afinitor For Advanced Kidney Cancer

March 27, 2009

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011